Inovio Pharmaceuticals (INO): Catalysts On The Horizon
Inovio Pharmaceuticals and their current pipeline, science, technology and the advantages to the DNA platform are reviewed. Read the analysis here.
Stay updated with breaking news from Factor Grades. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Inovio Pharmaceuticals and their current pipeline, science, technology and the advantages to the DNA platform are reviewed. Read the analysis here.
M/I Homes had an excellent FY '21 and a good second quarter but there were downtrends. See why we are moderately bullish on MHO stock.
EIX is 24% undervalued today, with strong earnings growth and growing dividends. Click here to read more.
UiPath is not profitable. A sell rating seems like the easiest and safest choice. Read why we argue the contrarian case and rate PATH stock a Strong Buy.
FOMC recap from a technical perspecive, bullish or bearish, and the Micron breakdown. Breaking down Micron's stock. Chris DeMuth Jr.